Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim C Honselmann

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Annals of Surgery|December 12, 2017
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOXTheodoros Michelakos, Ilaria Pergolini, Carlos Fernández-Del Castillo, et al.
Cancers|February 25, 2022
Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT)Louisa Bolm, Sergii Zemskov, Maria Zeller, et al.
JAMA Surgery|May 26, 2018
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic CancerMarta Sandini, Manuel Patino, Cristina R Ferrone, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Annals of Surgery|December 12, 2017
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOXTheodoros Michelakos, Ilaria Pergolini, Carlos Fernández-Del Castillo, et al.
Cancers|February 25, 2022
Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT)Louisa Bolm, Sergii Zemskov, Maria Zeller, et al.
JAMA Surgery|May 26, 2018
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic CancerMarta Sandini, Manuel Patino, Cristina R Ferrone, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Pageof 5